The private life of medicine: accounting for antibiotics in the 'for-profit' hospital setting
The private life of medicine: accounting for antibiotics in the 'for-profit' hospital setting
复制标题
DOI：
10.1057/s41285-018-0063-8
复制
发表时间：
2018-11-01
影响因子：
1.6
通讯作者：
Broom, Jennifer
中科院分区：
文献类型：
--
作者：
Broom, Alex;Gibson, Alexandra;Broom, Jennifer
迫在眉睫的全球抗生素危机，以及减少过度使用的必要性，被不同地定位为一个医疗问题，一个紧迫的公共卫生问题，以及一个治理和政治意愿的问题。但就其经济驱动因素而言，几乎没有人提出过问题。具体来说，感染管理和抗生素耐药性问题可能深深植根于经济需要和劳动关系。在澳大利亚一家私立医院采访了31名卫生专业人员（医生、护士、药剂师），我们探讨了他们对感染管理中的护理动态和经济必要性的描述。我们认为，市场驱动的力量创造了一套独特的义务，可能会破坏当地和全球抗生素优化议程。鉴于澳大利亚和国际上医疗保健的日益私有化，探索经济和实践的关系对于未来保留抗生素至关重要。
The looming global antibiotic crisis, and the need to curtail over-use, has been positioned variously as a medical problem, an urgent public health concern, and an issue of governance and political will. But few questions have been raised in terms of its economic drivers. Specifically, how infection management-and the problematic of antimicrobial resistance-may be deeply embedded in economic imperatives and relations of labour. Drawing on interviews with 31 health professionals (doctors, nurses, pharmacists) from a private hospital in Australia, we explore their accounts of the dynamics of care and the economic imperatives in (and beyond) infection management. We argue that market-driven forces create a distinct set of obligations that could undermine the local and global antibiotic optimisation agenda. Given the increasingly privatised landscape of healthcare in Australia and internationally, exploring the nexus of economics and practice will be vital in retaining antibiotics for the future.